If you have questions, please call us for more information about clinical trials or use our online form.
- Cancer clinical trials: 414-805-8900
- Noncancer clinical trials: 414-955-8555
Learn more about clinical trials basics and early-phase clinical trials, as well as some of the unique features our research program, including our Translational Research Unit. Froedtert & MCW health network is also part of the National Institutes of Health All of Us Research Program.
Displaying 211 - 220 of 270
Blood Flow Regulation and Neuromuscular Function Post-Stroke
Objective
Blood Flow Post Stroke
Protocol No
PMR-IIT-DURANT-BLOOD-FLOW
A Prospective, Multicountry Study To Estimate The Incidence Of And Provide A Best Practice Model For Monitoring The Development Of Post-Stroke Spasticity
Objective
Best Practice Model For Monitoring The Development Of Post-Stroke Spasticity
Protocol No
PMR-IPSEN-EPITOME
A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of iovera system in Subjects with Upper Extremity Spasticity
Objective
Iovera in Upper Extremity Spasticity
Protocol No
PMR-PACIRA-IOV-301
A Phase III Randomized Placebo-Controlled Study to Examine the Efficacy and Safety of DAS181 for the Treatment of Lower Respiratory Tract Parainfluenza Infection in Immunocompromised Subjects
Objective
Lower Respiratory Tract PIV Infection in Immunocompromised Subjects
Protocol No
PULM-ANSUN-BIOPHARMA-FQ
Categories
A Prospective Study Evaluating Maternal and Fetal Outcomes in the Era of Modulators (MAYFLOWERS)
Objective
Prospective Study of Pregnancy in Women With Cystic Fibrosis
Protocol No
PULM-CFF-MAYFLOWERS-OB-20
Categories
Reparixin 1200 mg TID as add-on to SoC to Limit Disease Progression in Hospitalised Patients With COVID-19 and Other Community-Acquired Pneumonia. A Multicentre, Randomised, Double-blinded, Placebo-controlled, Phase III Trial (REPAVID-22)
Objective
Reparixin as add-on to SOC to Limit Disease Progression in COVID-19 and Pneumonia
Protocol No
PULM-DOMPE-REPAVID-22
Categories
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Oral Inhalation of Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH)
Objective
Efficacy and Safety of Seralutinib in Adult Subjects With PAH (PROSERA)
Protocol No
PULM-GOSSAMER-PROSERA
Categories
A Randomized Controlled Trial of an iPad for Patient Communication during Mechanical Ventilation
Objective
iPad for Patient Communication
Protocol No
PULM-IPAD
Categories
A Randomized Controlled Trial of Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Objective
Postextubation Use of Noninvasive Respiratory Support in Severely Obese Patients
Protocol No
PULM-RUSH-POSTEXTUBATION
The Impact of Sarcopenic Obesity on Strength, Physical Functioning, and Pain Perception after Critical Illness
Objective
The Impact of Sarcopenic Obesity on Strength, Physical Functioning, and Pain Perception after Critical Illness
Protocol No
PULM-SOS-II
Categories